Neurological adverse events of mitotane in adrenocortical carcinoma: results of a pilot study.
Mormando M, Galiè E, Bianchini M, Lauretta R, Puliani G, Tanzilli A, Anceschi U, Simone G, Petreri G, Graziano G, Pace A, Appetecchia M.
Mormando M, et al. Among authors: lauretta r.
Front Oncol. 2023 Aug 14;13:1222002. doi: 10.3389/fonc.2023.1222002. eCollection 2023.
Front Oncol. 2023.
PMID: 37645432
Free PMC article.